[625,000% Gain] – Are You Ready for the Next Altcoin Boom?

All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.

IRON Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.24%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $23,529,140.76

Disc Medicine Insider Trading History Chart

Disc Medicine Share Price & Price History

^$62.55

▲ +3 (5.04%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

Financial Prophecy

From Porter & Company | Ad

The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold $3 billion of Amazon… it’s why Nvidia’s CEO just sold $713 million... and it’s why Zuckerberg just sold $1.3 billion in Meta stock. The financial establishment doesn’t want you to know about this… but a controversial new documentary just pulled back the curtain and exposed what’s really going on. It’s called The Final Frontier.

Including the name of the #1 company to buy.

Disc Medicine Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/15/2024	William Jacob Savage	Insider	Sell	9,158	$59.64	$546,183.12	40,405
11/4/2024	William Richard White	Director	Sell	7,136	$58.61	$418,240.96
11/1/2024	William Richard White	Director	Sell	201	$46.37	$9,320.37
10/1/2024	William Richard White	Director	Sell	201	$51.31	$10,313.31
8/1/2024	William Richard White	Director	Sell	201	$43.44	$8,731.44
4/11/2024	William Richard White	Director	Sell	2,560	$31.80	$81,408.00
1/23/2024	Kevin Bitterman	Director	Sell	102,500	$67.65	$6,934,125.00	198,326
1/23/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	47,500	$67.65	$3,213,375.00	1,402,186
1/10/2024	Kevin Bitterman	Director	Sell	20,000	$64.00	$1,280,000.00	786,160
1/10/2024	Venture Fund X L.P. Atlas	Major Shareholder	Sell	30,000	$64.00	$1,920,000.00	1,449,686
12/18/2023	Mona Ashiya	Director	Sell	1,724	$59.24	$102,129.76
12/14/2023	Orbimed Advisors Llc	Director	Sell	200	$57.73	$11,546.00	727,807
12/14/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	30,825	$58.28	$1,796,481.00	1,479,686
12/12/2023	Orbimed Advisors Llc	Director	Sell	27,300	$60.16	$1,642,368.00	295,605
12/12/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	77,951	$62.80	$4,895,322.80	1,515,834
12/5/2023	Joanne Bryce	CFO	Sell	2,541	$56.00	$142,296.00	2,500
11/22/2023	Rahul Khara	General Counsel	Sell	10,000	$51.73	$517,300.00
11/14/2023	Rahul Khara	General Counsel	Sell	4,900	$50.61	$247,989.00
11/3/2023	Rahul Khara	General Counsel	Sell	100	$50.00	$5,000.00
9/16/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	2,115	$53.22	$112,560.30	1,593,785
9/14/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	94,440	$53.05	$5,010,042.00	1,856,794
9/1/2023	Joanne Bryce	CFO	Sell	1,000	$52.99	$52,990.00	1,260
8/15/2023	Kevin Bitterman	Director	Sell	72,931	$52.40	$3,821,584.40	882,224
8/15/2023	William Jacob Savage	insider	Sell	7,672	$52.95	$406,232.40
8/14/2023	Venture Fund X L.P. Atlas	Major Shareholder	Sell	175,000	$52.59	$9,203,250.00	2,062,303
8/9/2023	William Jacob Savage	Insider	Sell	8,269	$49.83	$412,044.27	7,672
8/1/2023	Joanne Bryce	CFO	Sell	4,521	$49.91	$225,643.11	1,260
6/30/2023	Brian Richard Macdonald	Insider	Sell	4,324	$45.05	$194,796.20	12,876
6/28/2023	Holdings A/S Novo	Major Shareholder	Sell	1,250,000	$46.10	$57,625,000.00	1,090,772
6/28/2023	Joanne Bryce	CFO	Sell	10,072	$49.95	$503,096.40	1,260
6/28/2023	William Jacob Savage	Insider	Sell	4,384	$49.98	$219,112.32	15,941

Financial Prophecy

From Porter & Company | Ad

Including the name of the #1 company to buy.

SEC Filings (Institutional Ownership Changes) for Disc Medicine (NASDAQ:IRON)

83.70% of Disc Medicine stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Disc Medicine Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/18/2024	Teachers Retirement System of The State of Kentucky	19,560	$0.96M	0.0%	+38.7%	0.066%
11/16/2024	Geode Capital Management LLC	474,719	$23.33M	0.0%	+17.6%	1.597%
11/15/2024	Barclays PLC	40,145	$1.97M	0.0%	+123.7%	0.135%
11/15/2024	Y Intercept Hong Kong Ltd	9,057	$0.45M	0.0%	N/A	0.030%
11/15/2024	Jane Street Group LLC	24,731	$1.22M	0.0%	-23.7%	0.083%
11/15/2024	Wellington Management Group LLP	1,840,226	$90.43M	0.0%	+4.8%	6.190%
11/15/2024	State Street Corp	827,910	$40.68M	0.0%	+39.7%	2.785%
11/15/2024	Stifel Financial Corp	4,703	$0.23M	0.0%	-51.6%	0.016%
11/15/2024	Point72 Asset Management L.P.	755,867	$37.14M	0.1%	-0.7%	2.542%
11/15/2024	Janus Henderson Group PLC	749,827	$36.83M	0.0%	+68.2%	2.522%
11/15/2024	HighVista Strategies LLC	9,565	$0.47M	0.2%	N/A	0.032%
11/15/2024	Checkpoint Capital L.P.	25,543	$1.26M	0.6%	N/A	0.086%
11/14/2024	Verition Fund Management LLC	11,980	$0.59M	0.0%	N/A	0.040%
11/14/2024	Sio Capital Management LLC	187,941	$9.24M	3.7%	-2.1%	0.632%
11/14/2024	Walleye Capital LLC	209,236	$10.28M	0.0%	+53.7%	0.704%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	18,649	$0.92M	0.0%	+21.6%	0.063%
11/14/2024	Ally Bridge Group NY LLC	100,000	$4.91M	2.6%	-39.9%	0.336%
11/14/2024	MetLife Investment Management LLC	11,377	$0.56M	0.0%	+18.0%	0.038%
11/13/2024	Quantbot Technologies LP	2,964	$0.15M	0.0%	N/A	0.010%
11/13/2024	FMR LLC	406,814	$19.99M	0.0%	-1.5%	1.368%
11/13/2024	The Manufacturers Life Insurance Company	29,065	$1.43M	0.0%	+2.7%	0.098%
11/12/2024	Eagle Asset Management Inc.	83,215	$4.09M	0.0%	-15.7%	0.280%
11/12/2024	Charles Schwab Investment Management Inc.	160,554	$7.89M	0.0%	+13.7%	0.540%
11/9/2024	Intech Investment Management LLC	4,647	$0.23M	0.0%	N/A	0.016%
11/7/2024	Quest Partners LLC	2,670	$0.13M	0.0%	N/A	0.009%
11/5/2024	Victory Capital Management Inc.	220,014	$10.81M	0.0%	-29.5%	0.740%
10/25/2024	China Universal Asset Management Co. Ltd.	5,717	$0.28M	0.0%	+96.9%	0.023%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	1,075	$54K	0.0%	+45.7%	0.004%
10/3/2024	SG Americas Securities LLC	4,864	$0.24M	0.0%	+19.5%	0.020%
8/26/2024	Teachers Retirement System of The State of Kentucky	14,102	$0.64M	0.0%	N/A	0.057%
8/20/2024	Nantahala Capital Management LLC	150,000	$6.76M	0.4%	N/A	0.607%
8/16/2024	Perceptive Advisors LLC	553,437	$24.94M	0.6%	-13.5%	2.239%
8/16/2024	Algert Global LLC	5,298	$0.24M	0.0%	N/A	0.021%
8/16/2024	Frazier Life Sciences Management L.P.	1,754,834	$79.09M	3.7%	+123.5%	7.098%
8/15/2024	Blue Owl Capital Holdings LP	215,260	$9.70M	2.7%	+38.6%	0.871%
8/15/2024	The Manufacturers Life Insurance Company	28,294	$1.28M	0.0%	+26.7%	0.114%
8/15/2024	Deerfield Management Company L.P. Series C	1,023,265	$46.12M	0.8%	+53.8%	4.139%
8/14/2024	Point72 Asset Management L.P.	761,429	$34.32M	0.1%	N/A	3.080%
8/14/2024	Marshall Wace LLP	12,300	$0.55M	0.0%	N/A	0.050%
8/14/2024	Logos Global Management LP	925,000	$41.69M	3.3%	N/A	3.742%
8/14/2024	Ally Bridge Group NY LLC	166,500	$7.50M	4.5%	N/A	0.673%
8/14/2024	Profund Advisors LLC	4,586	$0.21M	0.0%	-70.9%	0.019%
8/12/2024	Amalgamated Bank	568	$26K	0.0%	+76.9%	0.002%
8/10/2024	Sofinnova Investments Inc.	29,256	$1.32M	0.1%	+373.9%	0.118%
8/9/2024	Atlas Venture Life Science Advisors LLC	2,509,456	$113.10M	11.9%	+9.7%	10.151%
8/8/2024	First Turn Management LLC	138,907	$6.26M	1.0%	-45.0%	0.562%
8/5/2024	Victory Capital Management Inc.	312,049	$14.06M	0.0%	+46.5%	1.262%
8/3/2024	TD Asset Management Inc	40,732	$1.84M	0.0%	+3.7%	0.165%
8/1/2024	Rhumbline Advisers	24,447	$1.10M	0.0%	+86.2%	0.099%
7/29/2024	Zurcher Kantonalbank Zurich Cantonalbank	2,867	$0.13M	0.0%	N/A	0.012%
7/26/2024	Bank of New York Mellon Corp	51,050	$2.30M	0.0%	+89.4%	0.207%
7/12/2024	SG Americas Securities LLC	4,071	$0.18M	0.0%	+44.2%	0.016%
5/16/2024	California State Teachers Retirement System	11,800	$0.74M	0.0%	+37.2%	0.048%
5/16/2024	Janus Henderson Group PLC	521,773	$32.47M	0.0%	+17.7%	2.114%
5/16/2024	Bain Capital Life Sciences Investors LLC	1,317,213	$82.01M	6.6%	-1.2%	5.337%
5/15/2024	Price T Rowe Associates Inc. MD	944,213	$58.79M	0.0%	+59.8%	3.826%
5/14/2024	StemPoint Capital LP	60,129	$3.74M	1.0%	-52.4%	0.244%
5/10/2024	Vanguard Group Inc.	782,751	$48.73M	0.0%	+2.4%	3.243%
5/9/2024	Lord Abbett & CO. LLC	119,312	$7.43M	0.0%	N/A	0.494%
5/8/2024	Bleakley Financial Group LLC	4,572	$0.29M	0.0%	+23.0%	0.019%
5/8/2024	ProShare Advisors LLC	3,385	$0.21M	0.0%	N/A	0.014%
5/7/2024	Swiss National Bank	23,800	$1.48M	0.0%	+50.6%	0.099%
5/7/2024	SG Americas Securities LLC	2,824	$0.18M	0.0%	-69.1%	0.012%
5/6/2024	Atlas Venture Life Science Advisors LLC	2,287,233	$142.40M	13.1%	-10.5%	9.475%
5/2/2024	Jennison Associates LLC	193,240	$12.03M	0.0%	+349.1%	0.800%
4/29/2024	China Universal Asset Management Co. Ltd.	4,641	$0.29M	0.0%	+66.2%	0.019%
4/24/2024	Simplicity Wealth LLC	4,566	$0.28M	0.0%	N/A	0.019%
3/22/2024	PNC Financial Services Group Inc.	10,000	$0.58M	0.0%	+149.4%	0.041%
3/5/2024	Wellington Management Group LLP	177,726	$10.27M	0.0%	+224.6%	0.736%
2/26/2024	Virtu Financial LLC	13,802	$0.80M	0.1%	N/A	0.057%
2/26/2024	Perceptive Advisors LLC	1,023,045	$59.09M	1.3%	+14.2%	4.238%
2/15/2024	Parkman Healthcare Partners LLC	92,871	$5.36M	0.8%	+78.4%	0.385%
2/15/2024	Frazier Life Sciences Management L.P.	785,000	$45.34M	2.4%	+19.8%	3.252%
2/14/2024	Pale Fire Capital SE	6,120	$0.35M	0.1%	N/A	0.025%
2/13/2024	Rafferty Asset Management LLC	39,863	$2.30M	0.0%	-36.9%	0.165%
2/12/2024	Fiduciary Trust Co	4,051	$0.23M	0.0%	N/A	0.017%
2/9/2024	Atlas Venture Life Science Advisors LLC	2,555,172	$147.59M	17.6%	-6.9%	10.585%
2/9/2024	Franklin Resources Inc.	221,424	$12.79M	0.0%	+37.5%	0.917%
2/9/2024	PNC Financial Services Group Inc.	10,000	$0.58M	0.0%	+149.4%	0.041%
2/8/2024	Nicholas Investment Partners LP	40,494	$2.34M	0.3%	N/A	0.168%
2/8/2024	First Turn Management LLC	157,274	$9.08M	1.3%	N/A	0.652%
2/7/2024	Jump Financial LLC	4,306	$0.25M	0.0%	N/A	0.018%
2/6/2024	Charles Schwab Investment Management Inc.	89,725	$5.18M	0.0%	+6.6%	0.372%
2/6/2024	AJOVista LLC	1,091	$63K	0.1%	N/A	0.005%
2/6/2024	Swiss National Bank	15,800	$0.91M	0.0%	-9.2%	0.065%
2/5/2024	Victory Capital Management Inc.	187,580	$10.84M	0.0%	+36.4%	0.777%
2/1/2024	New York State Common Retirement Fund	9,686	$0.56M	0.0%	+194.1%	0.040%
2/1/2024	Jennison Associates LLC	43,031	$2.49M	0.0%	N/A	0.178%
1/30/2024	Strs Ohio	1,000	$57K	0.0%	+66.7%	0.004%
1/29/2024	Simplicity Solutions LLC	3,716	$0.22M	0.0%	N/A	0.015%
1/25/2024	Bleakley Financial Group LLC	3,716	$0.22M	0.0%	N/A	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	2,793	$0.16M	0.0%	N/A	0.012%
1/16/2024	Legato Capital Management LLC	5,273	$0.31M	0.0%	N/A	0.022%
1/12/2024	SG Americas Securities LLC	9,135	$0.53M	0.0%	N/A	0.038%
12/18/2023	Vanguard Group Inc.	665,452	$31.26M	0.0%	+18.9%	2.757%
12/7/2023	Hudson Bay Capital Management LP	42,000	$1.97M	0.0%	N/A	0.174%
12/1/2023	Wellington Management Group LLP	54,745	$2.57M	0.0%	+26.5%	0.227%
11/22/2023	Polar Capital Holdings Plc	546,915	$25.69M	0.2%	-98.7%	2.266%
11/15/2023	Acuta Capital Partners LLC	138,198	$6.49M	4.4%	-0.9%	0.604%
11/15/2023	Adage Capital Partners GP L.L.C.	1,308,405	$61.47M	0.1%	+12.5%	5.719%

Data available starting January 2016

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

Today's Range

Now: $62.55

$59.10

$62.69

50 Day Range

MA: $51.79

$44.82

$66.57

52 Week Range

Now: $62.55

$25.60

$77.60

Volume

263,090 shs

Average Volume

354,389 shs

Market Capitalization

$1.86 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.6

Who are the company insiders with the largest holdings of Disc Medicine?: Disc Medicine's top insider shareholders include:
Venture Fund X LP Atlas (Major Shareholder)
Holdings A/S Novo (Major Shareholder)
Kevin Bitterman (Director)
Orbimed Advisors Llc (Director)
William Jacob Savage (Insider)
Brian Richard Macdonald (Insider)
Joanne Bryce (CFO)
Mona Ashiya (Director)
Rahul Khara (General Counsel)
William Richard White (Director)
Learn More about top insider investors at Disc Medicine.
Who are the major institutional investors of Disc Medicine?: Disc Medicine's top institutional investors include:
Wellington Management Group LLP — 6.19%
State Street Corp — 2.78%
Point72 Asset Management L.P. — 2.54%
Janus Henderson Group PLC — 2.52%
Geode Capital Management LLC — 1.60%
FMR LLC — 1.37%
Learn More about top institutional investors of Disc Medicine stock.
Which institutional investors are selling Disc Medicine stock?: In the previous quarter, IRON stock was sold by these institutional investors:
Victory Capital Management Inc.
Ally Bridge Group NY LLC
Eagle Asset Management Inc.
Jane Street Group LLC
FMR LLC
Point72 Asset Management L.P.
Stifel Financial Corp
Sio Capital Management LLC
Within the last year, company insiders that have sold Disc Medicine company stock include:
Venture Fund X LP Atlas (Major Shareholder)
Holdings A/S Novo (Major Shareholder)
Kevin Bitterman (Director)
Orbimed Advisors Llc (Director)
William Jacob Savage (Insider)
Brian Richard Macdonald (Insider)
Joanne Bryce (CFO)
Mona Ashiya (Director)
Learn More investors selling Disc Medicine stock.
Which institutional investors are buying Disc Medicine stock?: During the previous quarter, IRON stock was purchased by institutional investors including:
Janus Henderson Group PLC
State Street Corp
Wellington Management Group LLP
Walleye Capital LLC
Geode Capital Management LLC
Checkpoint Capital L.P.
Barclays PLC
Charles Schwab Investment Management Inc.